Cargando…

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies

Detalles Bibliográficos
Autores principales: Wong, Serre-Yu, Dixon, Rebekah, Martinez Pazos, Vicky, Gnjatic, Sacha, Colombel, Jean-Frederic, Cadwell, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055494/
https://www.ncbi.nlm.nih.gov/pubmed/33887219
http://dx.doi.org/10.1053/j.gastro.2021.04.025
_version_ 1783680460609552384
author Wong, Serre-Yu
Dixon, Rebekah
Martinez Pazos, Vicky
Gnjatic, Sacha
Colombel, Jean-Frederic
Cadwell, Ken
author_facet Wong, Serre-Yu
Dixon, Rebekah
Martinez Pazos, Vicky
Gnjatic, Sacha
Colombel, Jean-Frederic
Cadwell, Ken
author_sort Wong, Serre-Yu
collection PubMed
description
format Online
Article
Text
id pubmed-8055494
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher by the AGA Institute
record_format MEDLINE/PubMed
spelling pubmed-80554942021-04-20 Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies Wong, Serre-Yu Dixon, Rebekah Martinez Pazos, Vicky Gnjatic, Sacha Colombel, Jean-Frederic Cadwell, Ken Gastroenterology Brief Communication by the AGA Institute 2021-08 2021-04-20 /pmc/articles/PMC8055494/ /pubmed/33887219 http://dx.doi.org/10.1053/j.gastro.2021.04.025 Text en © 2021 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Communication
Wong, Serre-Yu
Dixon, Rebekah
Martinez Pazos, Vicky
Gnjatic, Sacha
Colombel, Jean-Frederic
Cadwell, Ken
Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
title Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
title_full Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
title_fullStr Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
title_full_unstemmed Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
title_short Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
title_sort serologic response to messenger rna coronavirus disease 2019 vaccines in inflammatory bowel disease patients receiving biologic therapies
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055494/
https://www.ncbi.nlm.nih.gov/pubmed/33887219
http://dx.doi.org/10.1053/j.gastro.2021.04.025
work_keys_str_mv AT wongserreyu serologicresponsetomessengerrnacoronavirusdisease2019vaccinesininflammatoryboweldiseasepatientsreceivingbiologictherapies
AT dixonrebekah serologicresponsetomessengerrnacoronavirusdisease2019vaccinesininflammatoryboweldiseasepatientsreceivingbiologictherapies
AT martinezpazosvicky serologicresponsetomessengerrnacoronavirusdisease2019vaccinesininflammatoryboweldiseasepatientsreceivingbiologictherapies
AT gnjaticsacha serologicresponsetomessengerrnacoronavirusdisease2019vaccinesininflammatoryboweldiseasepatientsreceivingbiologictherapies
AT colombeljeanfrederic serologicresponsetomessengerrnacoronavirusdisease2019vaccinesininflammatoryboweldiseasepatientsreceivingbiologictherapies
AT cadwellken serologicresponsetomessengerrnacoronavirusdisease2019vaccinesininflammatoryboweldiseasepatientsreceivingbiologictherapies
AT serologicresponsetomessengerrnacoronavirusdisease2019vaccinesininflammatoryboweldiseasepatientsreceivingbiologictherapies